B3GALT5 and cancer: B3GALT5 transcription thus represents a promising model to address such novel issues, since hypomethylation of distant sequences, acting on the LTR transcript, and promoter hypermethylation, acting on the native transcript [54,55], cooperate on one gene to obtain full cancer-associated silencing.